EFFECT OF METFORMIN ON WEIGHT REDUCTION AMONG DIABETIC AND NON-DIABETIC OBESE PATIENTS
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Benghazi, Benghazi, Libya.
- PharmD, Faculty of Pharmacy, Libyan International Medical University, Benghazi, Libya.
Abstract
Context: Metformin is the first line treatment in type II diabetes mellitus. In addition, it was used for weight reduction in both diabetic and non-diabetic obese patients.
Aims: The aim of this study was to examine the efficacy of metformin in weight reduction among diabetic and non-diabetic obese patient in Benghazi, Libya.
Settings and Design: a cross-sectional study
Methods and Material: A hundred well-designed a cross-sectional survey was distributed from January to December 2020 and filled by diabetic and non-diabetic obese patients (66 and 34, respectively) in Benghazi city.
Statistical analysis used: SPSS statistics soft wear (Version 21.0 SPSS Inc.: Chicago, IL, USA).
Results: Results had shown that 66.7 % of diabetic obese patients were more than 50 years while 35.5 % of non- diabetic obese patients were 21-25 years. 1-5 kg was the weight reduction in both diabetic and non-diabetic obese patients (43.9 % and 38.2 %, respectively)
Conclusions: According to this study, metformin is an effective therapy to reduce weight in diabetic and non-diabetic obese patients. Further studies are needed with exact weight reduction.
Keywords
Article Analytics
How to Cite This Article
Hanin F. Hussin, Sanad W. Alobidy, Fatma M. Bosafita and Iman E. Mohamed (2021); EFFECT OF METFORMIN ON WEIGHT REDUCTION AMONG DIABETIC AND NON-DIABETIC OBESE PATIENTS, Int. J. of Adv. Res., 9 (02), 893-897, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/12531
Corresponding Author
This work is licensed under a Creative Commons Attribution 4.0 International License.